Observe Medical ASA - Annual report 2020

Oslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): Attached Observe Medical ASA`s annual report for 2020. The report is also available on the company's website, www.observemedical.com

The annual report was reviewed and approved by the board of directors on April 29, 2021. The financial statements included in the annual report has no significant changes since the preliminary results for the full year 2020 reported on February 23, 2021.

For further information, please contact:

Björn Larsson, CEO. Mobile: +46 76 620 17 25 E-mail: bjorn.larsson@observemedical.com

Per Arne Nygård, CFO Mobile: +47 411 04 345 E-mail: perarne.nygard@observemedical.com

 

About Observe Medical

Observe Medical develops and markets and sells innovative hospital products that contribute to increased patient safety and a more efficient care system. The company’s ambition is to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in the areas of Urine measurement, Anesthesiology/ICUs and wound care, in combination with targeted M&A. The company’s headquarter is in Oslo, Norway and its operations is based out of Gothenburg, Sweden. Observe Medical has a direct sales organization in the Nordics and a distributor network internationally. Observe Medical's product Sippi® is the only automated digital urine meter with possibility for wireless data transfer to the hospital patient data management systems and hinders bacterial migration that can lead to urinary infections (Sippcoat®). Sippi® is CE marked and is currently being launched with focus on selected markets and hospitals in Nordics and in Europe.